Is PF 2341066 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use PF 2341066? Is PF 2341066 safe for nursing mother and child? Does PF 2341066 extracts into breast milk? Does PF 2341066 has any long term or short term side effects on infants? Can PF 2341066 influence milk supply or can PF 2341066 decrease milk supply in lactating mothers?
Answer by DrLact: About PF 2341066 usage in lactation
No information is available on the clinical use of PF 2341066 during breastfeeding. Because PF 2341066 is 91% bound to plasma proteins, the amount in milk is likely to be low. However, its half-life is about 42 hours and it might accumulate in the infant. The manufacturer recommends that breastfeeding be discontinued during PF 2341066 therapy and for 45 days after the last dose.
Alternate Drugs
Nivolumab(Unsafe)
Hydroxyurea(Low Risk)
Vinblastine(Dangerous)
Ipilimumab(Unsafe)
Etoposide(Dangerous)
Bleomycin(Dangerous)
Cetuximab(Unsafe)
Doxorubicin(Dangerous)
Vinorelbine(Dangerous)
Imatinib(Unsafe)
Carboplatin(Dangerous)
Cyclophosphamide(Dangerous)
Dacarbazine(Dangerous)
Paclitaxel(Dangerous)
Cisplatin(Unsafe)
Azelaic Acid(Safe)
Dasatinib(Unsafe)
Fluorouracil(Dangerous)
Busulfan(Dangerous)
Docetaxel(Dangerous)
Alemtuzumab(Low Risk)
Dactinomycin(Dangerous)
Rituximab(Low Risk)
Thioguanine(Dangerous)
Gemcitabine(Dangerous)
Bevacizumab(Low Risk)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Vincristine(Dangerous)
Tamoxifen(Dangerous)
Erlotinib(Unsafe)
Letrozole(Dangerous)
Mitoxantrone(Dangerous)
Trastuzumab(Unsafe)
Exemestane(Dangerous)
Mercaptopurine(Safe)
Cladribine(Dangerous)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Gemcitabine(Dangerous)
Orlistat(Low Risk)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Allopurinol(Safe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)